Roskamp Institute
2040 Whitfield Avenue
Sarasota
Florida
34243
United States
Tel: 941-752-2949
Fax: 941-752-2948
Website: http://www.roskampinstitute.com/
14 articles about Roskamp Institute
-
Biosplice Therapeutics Announces Department of Defense (DoD) Award to Fund Collaboration with The Roskamp Institute to Advance its Neurology Program
3/8/2024
Biosplice Therapeutics, Inc. announced that its collaboration with The Roskamp Institute, aimed at developing novel therapies for TBI using Biosplice’s promising small molecule DYRK inhibitors has been selected for funding by the DoD office of the Congressionally Directed Medical Research Programs.
-
New Roskamp Institute Clinical Research Shows Promise of Drug yo Slow Early-stage Alzheimer's Disease
3/6/2020
New data from a clinical trial of Alzheimer's Disease using a drug called Nilvadipine identified by researchers at the Roskamp Institute show that patients with very mild (very early stage) Alzheimer's disease show less cognitive decline over an 18-month period than placebo-treated patients. On the key clinical measure of memory, the
-
Just a Few Tickets Remain For Roskamp Institute's Grey Matters Symposium on Alzheimer's Disease Research
7/10/2018
The Roskamp Institute is pleased to announce that its second annual seminar, Grey Matters--A Symposium on Alzheimer's Disease Research, is nearly sold out.
-
Roskamp Institute Discovers New Target For Drugs To Treat Alzheimer's Disease
10/28/2014
-
Anavex Life Sciences Corp. Agreement With The Roskamp Institute To Advance The Clinical Development Of ANAVEX PLUS
1/13/2014
-
Star Scientific , Inc. Files Third-Quarter Financials For 2013; Comments On Company's Corporate Leadership Transition, Roskamp Institute Scientific Presentations At 2013 Annual Society For Neuroscience Convention
11/13/2013
-
Star Scientific , Inc.'s Rock Creek Pharmaceuticals Subsidiary Enrolls First Alzheimer's Study Patient at Roskamp Institute
8/24/2012
-
Rock Creek Pharmaceuticals Release: Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis
5/9/2012
-
Roskamp Institute Release: Key Clinical Trial of Alzheimer’s Disease Drug Begins in Europe
2/14/2012
-
Roskamp Institute Studies May Lead to Better Diagnosis and Eventual Treatment of Traumatic Brain Injuries
11/8/2011
-
Alzheimer’s Disease Drug Developed at Roskamp Institute Approved for Key Clinical Trial Funding in Europe
5/25/2011
-
Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceuticals RCP-006 Compound
2/28/2011
-
Star Scientific , Inc. Comments on Roskamp Institute's Plans to Conduct Human Alzheimer's Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
10/7/2010
-
Star Scientific , Inc. Announces Collaboration with Roskamp Institute on Beta-amyloid Discovery and Alzheimer's Disease
4/7/2010